US Stock MarketDetailed Quotes

Verrica Pharmaceuticals (VRCA)

Watchlist
  • 6.270
  • -0.100-1.57%
Close May 1 16:00 ET
  • 6.270
  • 0.0000.00%
Post 16:04 ET
107.71MMarket Cap-3.73P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verrica Pharmaceuticals (VRCA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
71.07%-17.63M
71.42%-4.59M
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
Net income from continuing operations
76.64%-17.89M
50.17%-8.07M
98.80%-274K
101.19%204K
52.08%-9.74M
-14.31%-76.58M
34.18%-16.2M
7.83%-22.86M
-56.38%-17.19M
-208.56%-20.33M
Operating gains losses
-131.82%-869K
-108.84%-229K
--34K
---420K
---254K
7.65%2.73M
4.60%2.59M
--0
----
----
Depreciation and amortization
-38.46%781K
-24.90%190K
-46.20%184K
-40.42%199K
-38.82%208K
51.79%1.27M
16.59%253K
62.86%342K
61.35%334K
68.32%340K
Other non cash items
48.73%3.28M
120.80%828K
31.01%1.09M
34.11%692K
38.92%671K
172.35%2.21M
-20.55%375K
--832K
--516K
--483K
Change In working capital
-408.44%-6.25M
149.08%2.01M
-28.01%7.93M
-385.45%-11.61M
-82.64%-4.59M
-79.44%2.03M
-184.06%-4.09M
4,021.71%11.02M
-152.32%-2.39M
-457.18%-2.51M
-Change in receivables
-222.61%-5.32M
1,423.29%1.93M
-2.29%10.04M
-348.11%-11.72M
-75.51%-5.58M
210.44%4.34M
57.56%-146K
363.58%10.28M
-2,135.04%-2.62M
-837.12%-3.18M
-Change in inventory
----
----
--218K
----
----
----
----
--0
----
----
-Change in prepaid assets
76.60%-264K
172.78%1.01M
-1,953.10%-2.09M
180.71%272K
142.82%546K
-292.16%-1.13M
188.33%371K
106.00%113K
-120.74%-337K
-200.71%-1.28M
-Change in payables and accrued expense
-31.67%-1.14M
102.05%87K
-270.15%-1.24M
-178.91%-505K
-74.26%520K
-106.39%-862K
-174.57%-4.25M
-86.97%727K
-79.59%640K
319.57%2.02M
-Change in other current liabilities
2.17%-315K
-22.39%-82K
18.56%-79K
1.27%-78K
3.80%-76K
-10.65%-322K
0.00%-67K
-25.97%-97K
-8.22%-79K
-6.76%-79K
-Change in other working capital
--782K
---782K
--1.08M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
71.07%-17.63M
71.42%-4.59M
213.17%9.69M
38.60%-10.04M
36.45%-12.68M
-57.94%-60.93M
-10.73%-16.06M
42.22%-8.56M
-250.35%-16.36M
-334.58%-19.95M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
0
Net PPE purchase and sale
--0
--0
--0
----
----
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
----
----
94.75%-19K
103.52%8K
75.38%-16K
81.36%-11K
--0
Financing cash flow
Cash flow from continuing financing activities
-96.17%1.45M
-65.40%13.64M
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
-49.16%37.73M
140,907.14%39.43M
-100.90%-397K
-661.90%-640K
-102.18%-661K
Net issuance payments of debt
-5,116.67%-48.2M
-9,527.27%-36.01M
-1,735.94%-3.98M
-1,351.51%-4.16M
-510.08%-4.06M
-102.10%-924K
-1,526.09%-374K
-100.49%-217K
--332K
---665K
Net common stock issuance
17.80%50.07M
----
----
----
----
40.27%42.5M
3,963,800.00%39.64M
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
2,114.29%155K
--1K
--0
--150K
-42.86%4K
Net other financing activities
89.51%-420K
----
----
----
----
-2,175.00%-4M
-89,966.67%-2.7M
-195.08%-180K
----
----
Cash from discontinued financing activities
Financing cash flow
-96.17%1.45M
-65.40%13.64M
-903.53%-3.98M
-549.22%-4.16M
-513.77%-4.06M
-49.16%37.73M
146,122.22%39.43M
-100.90%-397K
-661.90%-640K
-102.18%-661K
Net cash flow
Beginning cash position
-33.38%46.33M
-8.11%21.1M
-51.78%15.4M
-39.53%29.6M
-33.38%46.33M
102.92%69.55M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
102.92%69.55M
Current changes in cash
30.30%-16.18M
-61.28%9.05M
163.55%5.7M
16.52%-14.2M
18.80%-16.73M
-165.82%-23.22M
258.32%23.37M
-130.76%-8.97M
-253.47%-17.01M
-180.25%-20.61M
End cash Position
-34.93%30.15M
-34.93%30.15M
-8.11%21.1M
-51.78%15.4M
-39.53%29.6M
-33.38%46.33M
-33.38%46.33M
-72.77%22.96M
-42.09%31.93M
-18.37%48.94M
Free cash flow
71.08%-17.63M
71.42%-4.59M
212.96%9.69M
38.64%-10.04M
36.45%-12.68M
-56.54%-60.95M
-9.03%-16.06M
42.36%-8.57M
-246.21%-16.37M
-333.54%-19.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 71.07%-17.63M71.42%-4.59M213.17%9.69M38.60%-10.04M36.45%-12.68M-57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M-334.58%-19.95M
Net income from continuing operations 76.64%-17.89M50.17%-8.07M98.80%-274K101.19%204K52.08%-9.74M-14.31%-76.58M34.18%-16.2M7.83%-22.86M-56.38%-17.19M-208.56%-20.33M
Operating gains losses -131.82%-869K-108.84%-229K--34K---420K---254K7.65%2.73M4.60%2.59M--0--------
Depreciation and amortization -38.46%781K-24.90%190K-46.20%184K-40.42%199K-38.82%208K51.79%1.27M16.59%253K62.86%342K61.35%334K68.32%340K
Other non cash items 48.73%3.28M120.80%828K31.01%1.09M34.11%692K38.92%671K172.35%2.21M-20.55%375K--832K--516K--483K
Change In working capital -408.44%-6.25M149.08%2.01M-28.01%7.93M-385.45%-11.61M-82.64%-4.59M-79.44%2.03M-184.06%-4.09M4,021.71%11.02M-152.32%-2.39M-457.18%-2.51M
-Change in receivables -222.61%-5.32M1,423.29%1.93M-2.29%10.04M-348.11%-11.72M-75.51%-5.58M210.44%4.34M57.56%-146K363.58%10.28M-2,135.04%-2.62M-837.12%-3.18M
-Change in inventory ----------218K------------------0--------
-Change in prepaid assets 76.60%-264K172.78%1.01M-1,953.10%-2.09M180.71%272K142.82%546K-292.16%-1.13M188.33%371K106.00%113K-120.74%-337K-200.71%-1.28M
-Change in payables and accrued expense -31.67%-1.14M102.05%87K-270.15%-1.24M-178.91%-505K-74.26%520K-106.39%-862K-174.57%-4.25M-86.97%727K-79.59%640K319.57%2.02M
-Change in other current liabilities 2.17%-315K-22.39%-82K18.56%-79K1.27%-78K3.80%-76K-10.65%-322K0.00%-67K-25.97%-97K-8.22%-79K-6.76%-79K
-Change in other working capital --782K---782K--1.08M----------------------------
Cash from discontinued investing activities
Operating cash flow 71.07%-17.63M71.42%-4.59M213.17%9.69M38.60%-10.04M36.45%-12.68M-57.94%-60.93M-10.73%-16.06M42.22%-8.56M-250.35%-16.36M-334.58%-19.95M
Investing cash flow
Cash flow from continuing investing activities 00094.75%-19K103.52%8K75.38%-16K81.36%-11K0
Net PPE purchase and sale --0--0--0--------94.75%-19K103.52%8K75.38%-16K81.36%-11K--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--------94.75%-19K103.52%8K75.38%-16K81.36%-11K--0
Financing cash flow
Cash flow from continuing financing activities -96.17%1.45M-65.40%13.64M-903.53%-3.98M-549.22%-4.16M-513.77%-4.06M-49.16%37.73M140,907.14%39.43M-100.90%-397K-661.90%-640K-102.18%-661K
Net issuance payments of debt -5,116.67%-48.2M-9,527.27%-36.01M-1,735.94%-3.98M-1,351.51%-4.16M-510.08%-4.06M-102.10%-924K-1,526.09%-374K-100.49%-217K--332K---665K
Net common stock issuance 17.80%50.07M----------------40.27%42.5M3,963,800.00%39.64M--0--0--0
Proceeds from stock option exercised by employees --0--0--0--0--02,114.29%155K--1K--0--150K-42.86%4K
Net other financing activities 89.51%-420K-----------------2,175.00%-4M-89,966.67%-2.7M-195.08%-180K--------
Cash from discontinued financing activities
Financing cash flow -96.17%1.45M-65.40%13.64M-903.53%-3.98M-549.22%-4.16M-513.77%-4.06M-49.16%37.73M146,122.22%39.43M-100.90%-397K-661.90%-640K-102.18%-661K
Net cash flow
Beginning cash position -33.38%46.33M-8.11%21.1M-51.78%15.4M-39.53%29.6M-33.38%46.33M102.92%69.55M-72.77%22.96M-42.09%31.93M-18.37%48.94M102.92%69.55M
Current changes in cash 30.30%-16.18M-61.28%9.05M163.55%5.7M16.52%-14.2M18.80%-16.73M-165.82%-23.22M258.32%23.37M-130.76%-8.97M-253.47%-17.01M-180.25%-20.61M
End cash Position -34.93%30.15M-34.93%30.15M-8.11%21.1M-51.78%15.4M-39.53%29.6M-33.38%46.33M-33.38%46.33M-72.77%22.96M-42.09%31.93M-18.37%48.94M
Free cash flow 71.08%-17.63M71.42%-4.59M212.96%9.69M38.64%-10.04M36.45%-12.68M-56.54%-60.95M-9.03%-16.06M42.36%-8.57M-246.21%-16.37M-333.54%-19.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -